Zhang, H., Saha, J., Byun, J., Schin, M., Lorenz, M., Kennedy, R. T., . . . Brosius, F. C. (2008). Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. American Physiological Society.
Citação norma ChicagoZhang, Hongyu, et al. Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy. American Physiological Society, 2008.
MLA CitationZhang, Hongyu, et al. Rosiglitazone Reduces Renal and Plasma Markers of Oxidative Injury and Reverses Urinary Metabolite Abnormalities in the Amelioration of Diabetic Nephropathy. American Physiological Society, 2008.